Replies to post #320512 on Option Millionaires

[jimmybob]

Global Blood Therapeutics price target raised to $79 from $53 at Oppenheimer
Oppenheimer analyst Mark Breidenbach raised his price target for Global Blood Therapeutics to $79 from $53 given new clinical data and improved clarity on the performance of the Patient Reported Outcome instrument. The analyst reiterates an Outperform rating on the shares